These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4915309)

  • 21. [Excretion of catecholamines and their precursors in adolescents with toxico-infectious angiocardiopathies].
    Kaliuzhnaia RA; Matlina ESh; Muchinskaia SP
    Vopr Med Khim; 1971; 17(1):26-32. PubMed ID: 5555142
    [No Abstract]   [Full Text] [Related]  

  • 22. [The excretion of adrenaline, noradrenaline and their precursors (DOPA and dopamine) in migraine patients].
    Gol'dman NB; Matlina ESh; Fets AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(2):199-203. PubMed ID: 5439831
    [No Abstract]   [Full Text] [Related]  

  • 23. VII. Long persisting changes in catecholamine metabolism following addiction to and withdrawal from morphine.
    Sloan JW; Eisenman AJ
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():96-105. PubMed ID: 5749392
    [No Abstract]   [Full Text] [Related]  

  • 24. [Functional state of the sympatho-adrenal system in children with infectious nonspecific polyarthritis].
    Kolesov DV; Uvarova NN; Maslova OI
    Vopr Revm; 1968; 8(2):67-71. PubMed ID: 5742812
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of serum dopamine-beta-hydroxylase in essential hypertension.
    Yashima O; Ozawa M; Sato M; Suzuki K; Kimura T
    Jpn Circ J; 1974 Dec; 38(12):1085-8. PubMed ID: 4436937
    [No Abstract]   [Full Text] [Related]  

  • 26. Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmias and heart failure in patients with acute myocardial infarction.
    Jewitt DE; Mercer CJ; Reid D; Shillingford J; Thomas M; Valori C
    J Physiol; 1969 May; 202(1):24P-25P. PubMed ID: 5770896
    [No Abstract]   [Full Text] [Related]  

  • 27. [Dopamine and dopa as indices of reserve potential of the sympatho-adrenal system in pulmonary heart].
    Syvomiatnikova NV; Mel'nikova TO; Goncharova VA
    Ter Arkh; 1972 May; 44(5):94-6. PubMed ID: 5069087
    [No Abstract]   [Full Text] [Related]  

  • 28. The urinary excretion of DOPA (dihydroxyphenylalanine) in patients with acute myocardial infarction.
    Wocial B; Januszewicz W; Sznajderman M; Skórka B
    Clin Chim Acta; 1976 Jan; 66(2):273-6. PubMed ID: 1245074
    [No Abstract]   [Full Text] [Related]  

  • 29. [The syndrome of autonomic vascular dystonia in adolescents and young men with toxic-infectious processes].
    Kaliuzhnaia RA
    Kardiologiia; 1972 Oct; 12(10):91-5. PubMed ID: 4649483
    [No Abstract]   [Full Text] [Related]  

  • 30. [Administration of the catecholamine precursor, L-DOPA, for evaluating their in vivo biosynthesis in hypertension].
    Kiseleva ZM; Parfenova EV; Erina EV; Shkhvatsabaia IK
    Kardiologiia; 1979 Oct; 19(10):55-60. PubMed ID: 502171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Catecholamine determination in heart infarct].
    Gawellek F
    Z Gesamte Inn Med; 1966 Jun; 21(12):141-3. PubMed ID: 5987618
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative evaluation of catecholamine and dopa content in dermatoses].
    Broér BA
    Lab Delo; 1980; (4):224-6. PubMed ID: 6155548
    [No Abstract]   [Full Text] [Related]  

  • 33. Reactivity of the dopa-dopamine-noradrenaline-adrenaline system in epileptic patients.
    Karlov VA; Gleiser MA
    Neurosci Behav Physiol; 1986; 16(1):49-53. PubMed ID: 3090474
    [No Abstract]   [Full Text] [Related]  

  • 34. Correlation between catecholamine excretion and autonomic nervous system parameters in alcoholism.
    Govorin NV; Golodets RG; Bol'shakova TD; Rotenberg VS
    Hum Physiol; 1984; 10(3):192-200. PubMed ID: 6443565
    [No Abstract]   [Full Text] [Related]  

  • 35. [Catecholamine metabolism in manic-depressive psychosis].
    Usherenko LS
    Fiziol Zh; 1970; 16(3):393-9. PubMed ID: 5509683
    [No Abstract]   [Full Text] [Related]  

  • 36. Failure of enzyme inhibition therapy for malignant melanoma.
    Greer M; Anton AH; Williams CM
    Trans Am Neurol Assoc; 1969; 94():273-5. PubMed ID: 5374459
    [No Abstract]   [Full Text] [Related]  

  • 37. [Excretion of catecholamines and their precursors and indices of electrolyte balance in patients with chronic glomerulonephritis].
    Karpenko EI; Deĭneko VS
    Vrach Delo; 1972 Jan; 1():56-9. PubMed ID: 5017215
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes of catecholamine metabolism and symptoms of parkinsonism in rats with manganotoxicosis].
    Samoĭlova ZT; Shavolina VA
    Gig Tr Prof Zabol; 1974 Apr; 18(4):16-20. PubMed ID: 4845000
    [No Abstract]   [Full Text] [Related]  

  • 39. [The reserpine model of parkinsonism and changes in the metabolism of mediators].
    Tret'iakova KA; Samoĭlova ZT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):220-4. PubMed ID: 4743272
    [No Abstract]   [Full Text] [Related]  

  • 40. [Catecholamine metabolism in the tissue of malignant and benign tumors of the sympathetic nervous system].
    Käser H; Türler K; Burri PH
    Schweiz Med Wochenschr; 1971 Apr; 101(13):484-7. PubMed ID: 5558918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.